Trial NCT02072096

View at ClinicalTrials.gov 
Org. Study IDs: 14842
Secondary IDs: 2013-001473-24 F3Z-MC-IOQL

Last trial update was posted on 2019-10-09

MeSH Interventions

Acarbose Exenatide Glimepiride Insulin Glargine Linagliptin Liraglutide Metformin Pioglitazone Sitagliptin Phosphate

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

The trial was terminated per protocol because of lack of feasibility.

Limitations And Caveats

The trial was terminated per protocol due to lack of feasibility. All participants completed the first 24 weeks of the study. Some participants continued into the Core study. Data was assessed from Baseline to last participant visit, up to 72 weeks.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID